Cargando…

Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein

Interactions amongst different amyloid proteins have been proposed as a probable mechanism of aggregation and thus an important risk factor for the onset as well as progression of various neurodegenerative disorders including Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lat...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Meenakshi, Girdhar, Amandeep, Patel, Basant, Ganguly, Nirmal K., Kukreti, Ritushree, Taneja, Vibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859028/
https://www.ncbi.nlm.nih.gov/pubmed/29593496
http://dx.doi.org/10.3389/fnmol.2018.00075
_version_ 1783307734552150016
author Verma, Meenakshi
Girdhar, Amandeep
Patel, Basant
Ganguly, Nirmal K.
Kukreti, Ritushree
Taneja, Vibha
author_facet Verma, Meenakshi
Girdhar, Amandeep
Patel, Basant
Ganguly, Nirmal K.
Kukreti, Ritushree
Taneja, Vibha
author_sort Verma, Meenakshi
collection PubMed
description Interactions amongst different amyloid proteins have been proposed as a probable mechanism of aggregation and thus an important risk factor for the onset as well as progression of various neurodegenerative disorders including Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lateral Sclerosis. Evidences suggest that transthyretin (TTR), a plasma protein associated with transthyretin amyloidosis or familial polyneuropathy (FAP) interacts with heterologous amyloid proteins including amyloid beta and islet amyloid polypeptide. In addition, recent clinical studies have revealed the presence of systemic polyneuropathy associated with FAP mutations in patients with spinocerebral ataxia, amyotrophic lateral sclerosis, and new familial systematic prion disease. Hence, it is important to investigate the interactions amongst different amyloid proteins to gain better insight into the pathology of amyloid disorders. Yeast has been an excellent model system to study interaction/ cross-seeding between heterologous amyloid proteins, more because of presence of endogenous yeast prions. Here, we examined interactions of non-glutamine (non-Q)-rich transthyretin, with glutamine (Q)-rich yeast prion protein Sup35. We established aggregation of an engineered double (F87M/L110M) mutant M-TTR-GFP in yeast. This mutant is monomeric and readily formed aggregates compared to WT-TTR-GFP in yeast at acidic pH. Interestingly, aggregation of M-TTR-GFP was significantly enhanced in presence of [PSI(+)], an endogenous prion form of Sup35. Different variants of [PSI(+)] seeded M-TTR-GFP with different efficiencies and curing of [PSI(+)] (losing the prion form) in these strains reduced aggregation. Moreover, overexpression of prion domain of Sup35 fused to RFP (NM-RFP) also increased M-TTR-GFP aggregation. M-TTR-GFP and NM-RFP aggregates co-localized in perivacuolar and juxtranuclear region. Sup35 protein was even immunocaptured in M-TTR-GFP aggregates. However, M-TTR-GFP overexpression did not induce Sup35 aggregation. Thus, it appears to be a unidirectional interaction between these two amyloid proteins. However, no affect on M-TTR-GFP aggregation was observed due to another yeast prion, [PIN(+)]. Our findings thus show the molecular interaction of transthyretin with yeast prion and support that sequence similarity is not the prime requirement for heterologous amyloid interactions.
format Online
Article
Text
id pubmed-5859028
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58590282018-03-28 Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein Verma, Meenakshi Girdhar, Amandeep Patel, Basant Ganguly, Nirmal K. Kukreti, Ritushree Taneja, Vibha Front Mol Neurosci Neuroscience Interactions amongst different amyloid proteins have been proposed as a probable mechanism of aggregation and thus an important risk factor for the onset as well as progression of various neurodegenerative disorders including Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lateral Sclerosis. Evidences suggest that transthyretin (TTR), a plasma protein associated with transthyretin amyloidosis or familial polyneuropathy (FAP) interacts with heterologous amyloid proteins including amyloid beta and islet amyloid polypeptide. In addition, recent clinical studies have revealed the presence of systemic polyneuropathy associated with FAP mutations in patients with spinocerebral ataxia, amyotrophic lateral sclerosis, and new familial systematic prion disease. Hence, it is important to investigate the interactions amongst different amyloid proteins to gain better insight into the pathology of amyloid disorders. Yeast has been an excellent model system to study interaction/ cross-seeding between heterologous amyloid proteins, more because of presence of endogenous yeast prions. Here, we examined interactions of non-glutamine (non-Q)-rich transthyretin, with glutamine (Q)-rich yeast prion protein Sup35. We established aggregation of an engineered double (F87M/L110M) mutant M-TTR-GFP in yeast. This mutant is monomeric and readily formed aggregates compared to WT-TTR-GFP in yeast at acidic pH. Interestingly, aggregation of M-TTR-GFP was significantly enhanced in presence of [PSI(+)], an endogenous prion form of Sup35. Different variants of [PSI(+)] seeded M-TTR-GFP with different efficiencies and curing of [PSI(+)] (losing the prion form) in these strains reduced aggregation. Moreover, overexpression of prion domain of Sup35 fused to RFP (NM-RFP) also increased M-TTR-GFP aggregation. M-TTR-GFP and NM-RFP aggregates co-localized in perivacuolar and juxtranuclear region. Sup35 protein was even immunocaptured in M-TTR-GFP aggregates. However, M-TTR-GFP overexpression did not induce Sup35 aggregation. Thus, it appears to be a unidirectional interaction between these two amyloid proteins. However, no affect on M-TTR-GFP aggregation was observed due to another yeast prion, [PIN(+)]. Our findings thus show the molecular interaction of transthyretin with yeast prion and support that sequence similarity is not the prime requirement for heterologous amyloid interactions. Frontiers Media S.A. 2018-03-13 /pmc/articles/PMC5859028/ /pubmed/29593496 http://dx.doi.org/10.3389/fnmol.2018.00075 Text en Copyright © 2018 Verma, Girdhar, Patel, Ganguly, Kukreti and Taneja. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Verma, Meenakshi
Girdhar, Amandeep
Patel, Basant
Ganguly, Nirmal K.
Kukreti, Ritushree
Taneja, Vibha
Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein
title Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein
title_full Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein
title_fullStr Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein
title_full_unstemmed Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein
title_short Q-Rich Yeast Prion [PSI(+)] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein
title_sort q-rich yeast prion [psi(+)] accelerates aggregation of transthyretin, a non-q-rich human protein
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859028/
https://www.ncbi.nlm.nih.gov/pubmed/29593496
http://dx.doi.org/10.3389/fnmol.2018.00075
work_keys_str_mv AT vermameenakshi qrichyeastprionpsiacceleratesaggregationoftransthyretinanonqrichhumanprotein
AT girdharamandeep qrichyeastprionpsiacceleratesaggregationoftransthyretinanonqrichhumanprotein
AT patelbasant qrichyeastprionpsiacceleratesaggregationoftransthyretinanonqrichhumanprotein
AT gangulynirmalk qrichyeastprionpsiacceleratesaggregationoftransthyretinanonqrichhumanprotein
AT kukretiritushree qrichyeastprionpsiacceleratesaggregationoftransthyretinanonqrichhumanprotein
AT tanejavibha qrichyeastprionpsiacceleratesaggregationoftransthyretinanonqrichhumanprotein